Cobimetinib (Targeted Therapy) Plus Atezolizumab (Immunotherapy) in Participants With Advanced Melanoma Whose Cancer Has Worsened During or After Treatment With Previous Immunotherapy and Atezolizumab Monotherapy in Participants With Previously Untreated Advanced Melanoma

Cancer
Skin Cancer

Results
Download
Print

Study results

CO39721_LPS_2020Mar_Cohorts_A_and_B_ English.pdf (PDF, 1.9 MB)

CO39721_LPS_2020Mar_Cohort_C_English.pdf (PDF, 1.8 MB)

CO39721_LPS Cohort C 6 May_AF_ZA_v1.0_11Aug2020_FINAL.pdf (PDF, 0.4 MB)

CO39721_LPS Cohort C 6 May_UK_UA_v1.0_11Aug2020_FINAL.pdf (PDF, 0.4 MB)

CO39721_LPS Cohorts A and B 6 May_ES_ES_v1.0_11Aug2020_FINAL.pdf (PDF, 0.4 MB)

LPS_CO39721_Cohort C_ final results_24March2021_English (PDF, 0.4 MB)

LPS_CO39721_Cohorts A and B_ final results_24March2021_English (PDF, 0.4 MB)

What is Clinical Research?

In clinical research, volunteers, researchers, and medical professionals work together toward a shared goal: better treatment outcomes for patients. Clinical trials are vital to their process. They are carefully designed and follow approved protocols.

Cobimetinib (Targeted Therapy) Plus Atezolizumab (Immunotherapy) in Participants With Advanced Melanoma Whose Cancer Has Worsened During or After Treatment With Previous Immunotherapy and Atezolizumab Monotherapy in Participants With Previously Untreated Advanced Melanoma

Study results

CO39721_LPS_2020Mar_Cohorts_A_and_B_ English.pdf (PDF, 1.9 MB)

CO39721_LPS_2020Mar_Cohort_C_English.pdf (PDF, 1.8 MB)

CO39721_LPS Cohort C 6 May_AF_ZA_v1.0_11Aug2020_FINAL.pdf (PDF, 0.4 MB)

CO39721_LPS Cohort C 6 May_UK_UA_v1.0_11Aug2020_FINAL.pdf (PDF, 0.4 MB)

CO39721_LPS Cohorts A and B 6 May_ES_ES_v1.0_11Aug2020_FINAL.pdf (PDF, 0.4 MB)

LPS_CO39721_Cohort C_ final results_24March2021_English (PDF, 0.4 MB)

LPS_CO39721_Cohorts A and B_ final results_24March2021_English (PDF, 0.4 MB)

What is Clinical Research?

For the latest version of this information please go to www.forpatients.roche.com

Directly contact Roche for questions

Contact the hospital directly

Thank you

Something went wrong

Request a call back

Find participating medical centers and current study status in each of them

Cobimetinib (Targeted Therapy) Plus Atezolizumab (Immunotherapy) in Participants With Advanced Melanoma Whose Cancer Has Worsened During or After Treatment With Previous Immunotherapy and Atezolizumab Monotherapy in Participants With Previously Untreated Advanced Melanoma

For the latest version of this information please go to www.forpatients.roche.com